Expression of ErbB-3 and ErbB-4 protooncogene proteins in oral squamous cell carcinoma: A pilot study;Expresión de las proteínas de los proto-oncogenes ErbB-3 y ErbB-4 en el carcinoma oral de células escamosas: Estudio piloto

Medicina Oral

Volumn 8, Issue 5, 2003, Pages 374-381

  De Vicente, Juan Carlos ^a,d   Esteban, Isabel ^b   Germanà, Patricia ^c   Germanà, Antonino ^c   Vega, José Antonio ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

ErbB 3; ErbB 4; Immunohistochemistry; Oral cancer; Proto oncogenes

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MOUTH CARCINOMA; ONCOGENE; ONCOGENE ERB B3; ONCOGENE ERB B4; PILOT STUDY; SQUAMOUS CELL CARCINOMA;

EID: 0242653815     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and Neck Cancer. New Engl J Med 1993;328:184-92.
2. Alvi A, Myers EN, Johnson JT. Cancer of the Oral Cavity. En: Cancer of the Head and Neck Myers EN, Suen JY, eds. Philadelphia: WB Saunders Co; 1996. p. 321-60.
3. Renan MJ. How many mutations are requiered for tumorigenesis? Implications from human cancer data. Mol Carcinogenesis 1993;7:139-46.
4. Williams HK. Molecular pathogenesis of oral squamous cell carcinoma. J Clin Pathol: Mol Pathol 2000;53:165-72.
5. Hou L, Shi D. Tu SM, Zhang HZ, Hung MC, Ling D. Oral cancer progression and c-erbB-2/neu proto-oncogene expression. Cancer Lett 1992;65:215-20.
6. Ibrahim SO, Vasstrand EN, Liavaag PG. Johannessen AC, Lillehaug JR. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. Anticancer Res 1997;17:4539-46.
7. Kilpi A, Rich AM, Konttinen YT, Reade PC. Expression of c-erbB-2 protein in keratinocytes of oral mucosal lichen planus and subsequent squamous cell carcinoma. Eur J Oral Sci 1996;104:278-84.
8. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE. ErbB receptor-induced activation of stat transcription factors is mediated by src tyrosine kinases. J Biol Chem 1999;274:17209-18.
9. Tan M, Grijalva R, Yu D. Heregulin beta 1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal -regulated kinase. Cancer Res 1999:59:1620-5.
10. Kernohan NM, Blessing K, King G, Corbett IP, Miller ID. Expression of c-erbB2 oncoprotein in salivary gland tumors: an immunohistochemical study. J Pathol 1991;163:77-80.
11. Shintani S, Funayama T, Yoshihama Y, Alcalde RE, Ootsuki K, Terakado N, et al. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study. Anticancer Res 1995:15:2623-6.
12. Srinivasan R, Poulsom R, Hurst HC, Gullick WJ. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumor types. J Pathol 1998;185:236-45.
13. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, et al. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J 1996; 15:254-64.
14. Friess H, Fukuda A, Tang WH, Eichenberger A, Furlan N, Zimmermann A, et al. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3. World J Surg 1999;23:1010-18.
15. Shrestha P, Huang JW, Tsuji T, Shinozaki F, Maeda K, Sasaki K, et al. Rare expression of the c-erbB-2 oncoprotein in salivary gland tumors: an immunohistochemical study. J Oral Pathol Med 1992;21:477-80.
16. Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, et al. Differential expression of epidermal growth factor related proteins in human colorectal tumors. Proc Natl Acad Sci USA 1991;88:7792-6.
17. Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. Cancer Res 1996;56:1184-8.
18. Knowlden JM, Gee JM, Seery LT, Farrow L, Gullick WJ, Ellis IO, et at. c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene 1998;17:1949-57.
19. Sakurai K, Urade M, Takahashi Y, Kishimoto H, Noguchi K, Yasoshima H, et al. Increased expression of c-erbB-3 protein and proliferating cell nuclear antigen during development of verrucous carcinoma of the oral mucosa. Cancer 2000;89:2597-605.
20. Shintani S, Funayama T, Yoshihama Y, Alcalde RE, Matsumura T. Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma. Cancer Lett 1995;95:79-83.
21. Chang JL, Tsao YP, Liu DW, Han CP, Lee WH, Chen SL. The expression of type I growth receptors in the squamous neoplastic changes of uterine cervix. Gynecol Oncol 1999;73:62-71.
22. Gullick WJ, Srinivasan R. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer. Breast Cancer Res Treat 1998;52:43-53.
23. Suo Z, Emilsen E, Tveit KM, Nesland JM. Type 1 protein tyrosine kinases in benign and malignant breast lesions. Histopathology 1998;33: 514-21.
24. Werkmeister R, Brandt B, Joos U. The erbB oncogenes as prognostic markers in oral squamous cell carcinomas. Am J Surg 1996;172:681-3.
25. Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM. C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 1992;12:613-9.